Procter & Gamble Logo
US7427181091
852062
PG

Procter & Gamble

Cargando cotizaciones...

Previsión

El precio objetivo medio de los analistas es de 155,23 € (+0,82 %). La mediana es de 152,44 € (-0,99 %).

Comprar
  30
Mantener
  22
Vender
  1

Debates en la comunidad

  • Traducido del alemán

    Una acción. 20 años. Sin vender.

    Bakterius Bakterius II en Schnack

    12 41
  • Traducido del alemán

    Cómo lidiar con acciones de calidad que no rinden

    Das_Lama Das_Lama III en Schnack

    8 55
  • Gewinner laufen lassen/ Schäfchen ins Trockene bringen

    Parqet Nutzer Parqet Nutzer II en Schnack

    0 8
  • Regelmäßige Dividenden

    Bakterius Bakterius II en Schnack

    1 61
  • Traducido del alemán

    ¡Una acción para la eternidad! ¿Cuál elegiríais?

    MB Marc B. IV en Schnack

    2 20

  • Procter & Gamble impresses with 70 years of dividend growth and stable revenue

    Procter & Gamble has increased its dividend for 70 consecutive years and has paid uninterrupted dividends for 136 years. In the most recent quarter, revenue rose organically by 4 percent, and operating cash flow was $5.8 billion. In fiscal 2026, more than $10 billion was paid in dividends and around $5 billion went to share buybacks. The stock, with a forward P/E of about 24, is not cheap but—thanks to strong brands and stable cash flows—offers defensive stability compared with volatile tech names. » Más en deraktionaer.de


  • Procter & Gamble confirms profit forecast despite sharply higher costs

    In the first fiscal quarter 2026/27, Procter & Gamble’s revenue rose 4.0% to USD 23.28 billion, with organic growth (adjusted) also at 4.0%; adjusted earnings per share climbed to USD 2.00 and beat expectations. The adjusted EBIT margin fell from 26.7% to 25.9% due to significantly higher raw material and transportation costs. Management slightly raised the sales outlook (2–4%), confirmed the adjusted EPS guidance of USD 6.89–7.11, and plans share buybacks and dividend payments of several billion dollars each; at the same time, higher raw material, interest and currency effects weighed on results. » Más en finanzen.net


  • Procter & Gamble starts the 2026/27 fiscal year strongly

    The US consumer goods giant Procter & Gamble reported organic sales growth of 4% to $23.3 billion for the three months ended September, driven mainly by volumes with only modestly higher prices. Net income was about $4.7 billion, roughly flat year-on-year, and adjusted earnings per share rose 1% to $2.00. P&G confirmed its full-year targets: adjusted EPS to be flat to +3% ($6.89–$7.11) and organic sales growth of 1–3%; including the acquisition of Thorne, sales are expected to increase 2–4%. The stock rose just over 5% in early trading. » Más en finanzen.net


  • Procter & Gamble hits 70th consecutive annual dividend increase amid steady fiscal 2026 results

    Procter & Gamble extended its dividend streak to 70 years and yields nearly 3%, supported by fiscal 2026 revenue of about $87 billion (up 3%) and EPS of $6.62 (up 2%). Moody's upgraded the company's credit outlook to positive, citing sustainable free cash flow and earnings growth. The stock is down roughly 8% year‑over‑year and trades at forward and trailing P/E ratios above 20, suggesting it is not inexpensive despite the reliable payout. » Más en finance.yahoo.com


  • Moody’s raises outlook for Procter & Gamble to positive after strong cash flow

    Moody’s has confirmed the ratings for Procter & Gamble and Gillette (Aa3/Prime-1) and has raised the rating outlook from stable to positive. The change is justified by sustained free cash flow, strong earnings growth driven by price increases, innovation and cost reductions, and solid credit metrics (retained cash flow/net debt well above 25%, debt/EBITDA below 2). The acquisition of Thorne for USD 3.8 billion will pro forma temporarily increase the leverage ratio to just above 1.6x, but is expected to decline again through integration, scale effects and cost optimization. Moody’s cites potential upgrades or downgrades depending on market shares, profitability, free cash flow and the company’s financial policy. » Más en de.investing.com

En 2026, Procter & Gamble ya ha pagado 2,77 € en dividendos. El último pago fue en agosto.

Datos financieros de la empresa

En el último trimestre, Procter & Gamble tuvo unos ingresos de 20,55 mil M € y un beneficio neto de 4176,76 M €
(EUR) septiembre de 2026
YoY
Ingresos 20,55 mil M 7,72 %
Beneficio bruto 10,24 mil M 4,50 %
Beneficio neto 4176,76 M 3,19 %
EBITDA 6229,39 M 4,55 %

Datos fundamentales

Métrica Valor
Capitalización bursátil
357,12 mil M €
Número de acciones
2317,78 M
Máximo/mínimo de 52 semanas
154,92 € - 124,88 €
Rentabilidad por dividendo
2,39 %
Dividendos TTM
3,68 €
Próximo dividendo
0,99 €
Beta
0,36
Ratio P/E
25,16
Ratio PEG
-6,32
Ratio P/B
7,42
Ratio P/S
4,48

Perfil de la empresa

The Procter & Gamble Company suministra productos de consumo envasados de marca a consumidores en Norteamérica y Latinoamérica, Europa, Asia Pacífico, la Gran China, India, Oriente Medio y África. Opera en cinco segmentos: Belleza; Cuidado Masculino; Cuidado de la Salud; Cuidado de Telas y del Hogar; y Cuidado de Bebés, Femenino y Familiar. El segmento de Belleza ofrece acondicionadores, champús, productos para el peinado y tratamientos; y antitranspirantes y desodorantes, productos de limpieza personal y de cuidado de la piel bajo las marcas Head & Shoulders, Herbal Essences, Pantene, Rejoice, Olay, Old Spice, Safeguard, Secret y SK-II. The Procter & Gamble Company se fundó en 1837 y tiene su sede central en Cincinnati, Ohio.

Nombre
Procter & Gamble
CEO
Shailesh G. Jejurikar
Sede Cincinnati, oh
Estados Unidos
Sitio web
Sector
Consumo básico
Industria
Productos para el hogar
Salida a bolsa
02/01/1962
Empleados 104.000

Símbolos bursátiles

Bolsa Símbolo
NYSE
PG
XETRA
PRG.DE
Frankfurt
PRG.F
Düsseldorf
PRG.DU
Hamburg
PRG.HM
Milan
1PG.MI
London
0NOF.L
SIX
PG.SW
München
PRG.MU
Wien
PG.VI
🍪

Parqet  usa cookies. Más información